Hemato is an open access, peer-reviewed journal that focuses on advances in the field of Hematology. It covers various disciplines within hematology and welcomes multidisciplinary research. The journal has published a total of 145 articles so far, with a peak of 83,404 downloads in 2022. It has also published special issues on relevant topics and launched a "What's new" series. Hemato was indexed by Scopus and Web of Science in 2023. The journal has future goals of improving communication, including more young researchers, and organizing webinars for collaboration. It plans to launch two series in 2024, focusing on TME modulators in Hodgkin lymphomas and other B-cell lymphomas, and immune deficiency/dysregulation-associated lymphoproliferative disorders. These series will explore recent scientific acquisitions and their clinical applications. [Extracted from the article]